Last reviewed · How we verify
NCT06722573
Mechanisms of Mindfulness Intervention：Rumination Behavioral Experiments
NA trial testing Mindfulness Intervention for Emotional Distress(MIED)-normal version in Emotional Distress in 160 participants. Not yet recruiting.
20 February 2025
Quick facts
| Lead sponsor | Peking University |
|---|---|
| Phase | NA |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | supportive care |
| Enrollment | 160 |
| Start date | 10 December 2024 |
| Primary completion | 20 February 2025 |
| Estimated completion | 10 June 2025 |
Drugs / interventions tested
- Mindfulness Intervention for Emotional Distress(MIED)-normal version
Conditions studied
- Emotional Distress — all drugs for Emotional Distress →
Sponsor
Peking University
Who can join
Adults 18 to 55, any sex, with Emotional Distress. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study hopes to explore whether the changes in rumination exhibited in behavioral experiments mediates the effects of mindfulness intervention on alleviating emotional distress
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06722573
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Mindfulness Intervention for Emotional Distress(MIED)-normal version
Trials testing the same drug.
- NCT06622122 — Mechanisms of Mindfulness Intervention: Cognitive Flexibility Dose Manipulation · NA · not yet recruiting
- NCT06056232 — Mechanisms of Mindfulness Intervention: Distress Tolerance Dose Manipulation · NA · unknown
Other recruiting trials for Emotional Distress
Currently open trials in the same condition.
- NCT07436845 — Impact of Emotional Status on Prognosis of Patients With BCLC Stage B/C Hepatocellular Carcinoma Undergoing Hepatic Arte · recruiting
- NCT06713460 — Emotional Intelligence Intervention to Improve Mental Well-Being of Adolescents With Emotional Distress (BEAM) · NA · recruiting
- NCT05712057 — Neurostimulation Versus Therapy for Problems With Emotions · NA · recruiting
- NCT05639465 — Intervention to Prevent Behavioral Health Symptoms Among Pandemic Affected Children · NA · recruiting
Other Peking University trials
Trials by the same sponsor.
- NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
- NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
- NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
- NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
- NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06722573 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University
- Last refreshed: 9 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06722573.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing